Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

March 24, 2015 Leave a comment 6,239 Views

MOUNTAIN VIEW, Calif., March 23, 2015 /PRNewswire/ — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Ludwig Cancer Research

Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

Exogene – A performant workflow for detecting viral integrations from paired-end next-generation sequencing data

RNALocate v2.0 – an updated resource for RNA subcellular localization with increased coverage and annotation

A precision oncology framework to predict patient response to cancer therapy from the tumor transcriptome

A comparison of DNA and RNA sequencing of total nucleic acids for metagenomics

New software unveils the relationships between RNA modifications and cancers

Postdoc Position Available – Neurosurgery

Transcriptomic entropy – a biologically relevant and interpretable metric for quantifying PSC-derived tissue maturation